Top 2 Health Care Stocks That May Fall Off A Cliff This Month
Top 2 Health Care Stocks That May Fall Off A Cliff This Month
As of Oct. 25, 2024, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
截至2024年10月25日，醫療保健板塊的兩隻股票可能會向那些將動量視爲交易決策關鍵標準的投資者發出真正的警告。
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro.
RSI是一種動量指標，它將股票在股價上升的日子裏的強度與在股價下跌的日子裏的強度進行比較。與股票價格的走勢相比，它可以讓交易員更好地了解股票在短期內的表現。當RSI高於70時，資產通常被認爲是超買的，據Benzinga Pro稱。
Here's the latest list of major overbought players in this sector.
以下是行業中超買的主要股票列表。
Immunitybio Inc (NASDAQ:IBRX)
Immunitybio公司（納斯達克: IBRX）
- On Oct. 24, ImmunityBio said it dosed its first patients in its Phase 1 clinical study of CAR-NK cell therapy for relapsed B-Cell Non-Hodgkin Lymphoma. The company's stock gained around 20% over the past five days and has a 52-week high of $10.53.
- RSI Value: 76.65
- IBRX Price Action: Shares of Immunitybio gained 21.7% to close at $4.21 on Thursday.
- 10月24日，ImmunityBio宣佈在其CAR-Nk細胞治療對複發性b-細胞非何傑金淋巴瘤的一期臨床研究中給首批患者服用藥物。該公司股價在過去五天上漲約20%，並創下了52周的最高價10.53美元。
- RSI數值：76.65
- IBRX價格走勢：Immunitybio股票週四上漲21.7%，收盤價爲4.21美元。
Scholar Rock Holding Corp (NASDAQ:SRRK)
Scholar Rock Holding Corp（納斯達克：SRRK）
- On Oct. 8, Scholar Rock announced the pricing of upsized $300 million public offering of common stock and pre-funded warrants. The company's stock gained around 237% over the past month and has a 52-week high of $35.38.
- RSI Value: 70.14
- SRRK Price Action: Shares of Scholar Rock rose 3.8% to close at $29.01 on Thursday.
- Scholar Rock宣佈定價爲30,000萬美元的普通股和預融資認股權的增發。該公司股價在過去一個月上漲約237%，創下35.38美元的52周高點。
- RSI值：70.14
- SRRk價格走勢：Scholar Rock的股價週四上漲3.8%，收於29.01美元。
Read More:
閱讀更多：
- Jim Cramer Says 'Hold On' To Palantir, 'Let Them Walk It Up'; Warns That Travere Therapeutics Is Losing A 'Ton Of Money'
- 吉姆·克萊默表示"持有"Palantir，"讓他們走高"；警告Travere Therapeutics正在"虧損一大筆錢"
譯文內容由第三人軟體翻譯。
